Following positive clinical results, retatrutide, a novel peptide treatment for treating type 2 diabetes , has secured regulatory approval from Great Britain's Healthcare and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/